Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.120
-0.030 (-2.61%)
At close: Oct 23, 2026, 4:00 PM EDT
1.140
+0.020 (1.79%)
After-hours: Oct 23, 2026, 7:30 PM EDT
Cardiol Therapeutics Market Cap
Cardiol Therapeutics has a market cap or net worth of $132.8 million as of October 23, 2026. Its market cap has increased by 32.85% in one year.
Market Cap
132.80M
Enterprise Value
114.23M
1-Year Change
32.85%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since December 20, 2018, Cardiol Therapeutics's market cap has increased from $69.77M to $132.80M, an increase of 90.35%. That is a compound annual growth rate of 8.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 132.80M | 39.68% |
| Dec 31, 2025 | 95.08M | -9.38% |
| Dec 31, 2024 | 104.92M | 93.06% |
| Dec 29, 2023 | 54.35M | 67.34% |
| Dec 30, 2022 | 32.48M | -71.06% |
| Dec 31, 2021 | 112.23M | 56.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lifecore Biomedical | 241.12M |
| SIGA Technologies | 226.33M |
| Glass House Brands | 214.87M |
| ADC Therapeutics | 204.27M |
| Akebia Therapeutics | 155.79M |
| Journey Medical | 143.66M |
| Organogenesis Holdings | 132.53M |
| Organigram Global | 130.61M |